Change of B-Type Natriuretic Peptide After Surgery and Its Association With Rhythm Status in Patients With Chronic Severe Mitral Regurgitation

Canadian Journal of Cardiology

Volumn 29, Issue 6, 2013, Pages 704-711

  Hwang, In Chang ^a,b   Kim, Dae Hee ^a,b   Kim, Yong Jin ^a,b   Kim, Kyung Hee ^a,b   Lee, Seung Pyo ^a,b   Kim, Hyung Kwan ^a,b   Sohn, Dae Won ^a,b   Oh, Byung Hee ^a,b   Park, Young Bae ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; CHRONICITY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART RHYTHM; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROSPECTIVE STUDY; PULMONARY ARTERY; SINUS RHYTHM; SYSTOLIC BLOOD PRESSURE;

BIOLOGICAL MARKERS; CHRONIC DISEASE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HEART VALVE PROSTHESIS; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; NATRIURETIC PEPTIDE, BRAIN; POSTOPERATIVE PERIOD; PROGNOSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; VENTRICULAR FUNCTION, LEFT;

EID: 84878159739     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2012.09.006     Document Type: Article

References (31)

1. Sutton T.M., Stewart R.A., Gerber I.L., et al. Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation. J Am Coll Cardiol 2003, 41:2280-2287.
2. Detaint D., Messika-Zeitoun D., Avierinos J.F., et al. B-type natriuretic peptide in organic mitral regurgitation: determinants and impact on outcome. Circulation 2005, 111:2391-2397.
3. Pizarro R., Bazzino O.O., Oberti P.F., et al. Prospective validation of the prognostic usefulness of brain natriuretic peptide in asymptomatic patients with chronic severe mitral regurgitation. J Am Coll Cardiol 2009, 54:1099-1106.
4. Morimoto K., Mori T., Ishiguro S., Matsuda N., Hara Y., Kuroda H. Perioperative changes in plasma brain natriuretic peptide concentrations in patients undergoing cardiac surgery. Surgery Today 1998, 28:23-29.
5. Georges A., Forestier F., Valli N., Plogin A., Janvier G., Bordenave L. Changes in type B natriuretic peptide (BNP) concentrations during cardiac valve replacement. Eur J Cardiothorac Surg 2004, 25:941-945.
6. Krishnaswami A., Jang J.J., Berkheimer S., Pompili M., Lee H. No change in B-type natriuretic peptide levels assessed in the late postoperative period in patients with severe mitral regurgitation after mitral valve surgery. Interact Cardiovasc Thorac Surg 2011, 12:768-771.
7. Filsoufi F., Rahmanian P.B., Salzberg S., von Harbou K., Bodian C.A., Adams D.H. B-type natriuretic peptide (BNP) in patients undergoing mitral valve surgery. J Cardiac Surg 2008, 23:600-605.
8. Grigioni F., Avierinos J.F., Ling L.H., et al. Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome. J Am Coll Cardiol 2002, 40:84-92.
9. Eguchi K., Ohtaki E., Matsumura T., et al. Pre-operative atrial fibrillation as the key determinant of outcome of mitral valve repair for degenerative mitral regurgitation. Eur Heart J 2005, 26:1866-1872.
10. Alexiou C., Doukas G., Oc M., et al. The effect of preoperative atrial fibrillation on survival following mitral valve repair for degenerative mitral regurgitation. Eur J Cardiothorac Surg 2007, 31:586-591.
11. Bonow R.O., Carabello B.A., Chatterjee K., et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008, 118:e523-e661.
12. Kim J.B., Ju M.H., Yun S.C., et al. Mitral valve replacement with or without a concomitant Maze procedure in patients with atrial fibrillation. Heart 2010, 96:1126-1131.
13. Bando K., Kasegawa H., Okada Y., et al. Impact of preoperative and postoperative atrial fibrillation on outcome after mitral valvuloplasty for nonischemic mitral regurgitation. J Thorac Cardiovasc Surg 2005, 129:1032-1040.
14. Page P. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: surgical therapy. Can J Cardiol 2011, 27:67-73.
15. Inoue S., Murakami Y., Sano K., Katoh H., Shimada T. Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation. J Card Fail 2000, 6:92-96.
16. Jourdain P., Bellorini M., Funck F., et al. Short-term effects of sinus rhythm restoration in patients with lone atrial fibrillation: a hormonal study. Eur J Heart Fail 2002, 4:263-267.
17. Albage A., Kenneback G., van der Linden J., Berglund H. Improved neurohormonal markers of ventricular function after restoring sinus rhythm by the Maze procedure. Ann Thorac Surg 2003, 75:790-795.
18. Lang R.M., Bierig M., Devereux R.B., et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005, 18:1440-1463.
19. Detaint D., Messika-Zeitoun D., Chen H.H., et al. Association of B-type natriuretic peptide activation to left ventricular end-systolic remodeling in organic and functional mitral regurgitation. Am J Cardiol 2006, 97:1029-1034.
20. Wazni O.M., Martin D.O., Marrouche N.F., et al. Plasma B-type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery. Circulation 2004, 110:124-127.
21. Gibson P.H., Croal B.L., Cuthbertson B.H., et al. Use of preoperative natriuretic peptides and echocardiographic parameters in predicting new-onset atrial fibrillation after coronary artery bypass grafting: a prospective comparative study. Am Heart J 2009, 158:244-251.
22. Kim Y.H., Lee S.C., Her A.Y., et al. Preoperative left atrial volume index is a predictor of successful sinus rhythm restoration and maintenance after the maze operation. J Thorac Cardiovasc Surg 2007, 134:448-453.
23. Antonini-Canterin F., Beladan C.C., Popescu B.A., et al. Left atrial remodelling early after mitral valve repair for degenerative mitral regurgitation. Heart 2008, 94:759-764.
24. Song B.G., Park S.J., Jeon E.S., et al. Preoperative N-terminal pro-B type natriuretic peptide level can predict the regression of left ventricular mass after valvular surgery in patients with chronic severe mitral regurgitation: one-year follow-up. Int J Cardiol 2010, 145:203-208.
25. Rossi A., Enriquez-Sarano M., Burnett J.C., Lerman A., Abel M.D., Seward J.B. Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study. J Am Coll Cardiol 2000, 35:1256-1262.
26. Kim K.H., Kim Y.J., Lee S.P., et al. Survival, exercise capacity, and left ventricular remodeling in a rat model of chronic mitral regurgitation: serial echocardiography and pressure-volume analysis. Korean Circ J 2011, 41:603-611.
27. Loke I., Squire I.B., Davies J.E., Ng L.L. Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate. Eur J Heart Fail 2003, 5:599-606.
28. Kim H.K., Kim Y.J., Chung J.W., Sohn D.W., Park Y.B., Choi Y.S. Impact of left ventricular diastolic function on exercise capacity in patients with chronic mitral regurgitation: an exercise echocardiography study. Clin Cardiol 2004, 27:624-628.
29. Le Tourneau T., de Groote P., Millaire A., et al. Effect of mitral valve surgery on exercise capacity, ventricular ejection fraction and neurohormonal activation in patients with severe mitral regurgitation. J Am Coll Cardiol 2000, 36:2263-2269.
30. Yoon C.H., Zo J.H., Kim Y.J., et al. B-type natriuretic peptide in isolated severe tricuspid regurgitation: determinants and impact on outcome. J Cardiovasc Ultrasound 2010, 18:139-145.
31. Kim Y.J., Kwon D.A., Kim H.K., et al. Determinants of surgical outcome in patients with isolated tricuspid regurgitation. Circulation 2009, 120:1672-1678.